Go to Page # Page of 35

Immunotherapy for Cancer: Promises and Challenges

 Edmund K. Waller MD PhD FACP
  4th-Jul-2016
Description: Cancer is a genetic disease that results from sequential mutations. Why don’t vaccines work better to treat cancer? Immunity is a balance between action and restraint. Signaling pathways between T-cells and dendritic cells regulate T-cell activation status. Activity of Anti–PD-1 Antibody in Patients with Treatment-Refractory Melanoma, Non–Small-Cell Lung Cancer, or Renal-Cell Cancer. Activity of Anti–PD-L1 Antibody in Patients with Advanced Melanoma and Non–Small-Cell Lung Cancer. Relationship between PD-L1 Expression and response rates in lung cancer.
Views: 1226
Domain: Medical
Category: Therapy
Contributing Organization: World Stem Cell Summit
 ‐ More of their Presentations
weSRCH App on Apple
Contents:
Immunotherapy for Cancer
Promises and Challenges
Edmund K. Waller, MD, PhD, FACP

Cancer is a genetic disease that
results from sequential mutations

Types of Tumor Antigens Recognized by T Cells

Cancer Immunotherapy has been
disappointing

Why don’t vaccines work better to treat cancer?
Immunity is a balance between action and restraint

Signaling pathways between T-cells and dendriti ... See more

Recent Presentations

...
21 May, 2018

Senhwa Biosciences, Inc

The information contained in this confidential document (“Presentation”) has been prepared by Senhwa Biosciences (the "Company"). It has not been fully verified and is subject to m

...
19 May, 2018
...
18 May, 2018